AFP and hepatocellular carcinoma: In the present study PIVKA-II and AFP increased in HCC, which is in accordance with previous studies [68] reporting that (PIVKA-II) increased in the serum of HCC patients because of an acquired defect in the posttranslational carboxylation of the prothrombin precursor in malignant cells.